structural variant analysis
The clinical whole-genome sequencing and analysis firm is planning to add Oxford Nanopore long-read sequencing to all samples by the end of the year.
The company is also working on a new Saphyr system that will have 14 times higher throughput than the current one, which can analyze 5,000 human genomes per year.
Bionano Prices $18M Stock, Warrant Offering
The company is also participating in a study, being conducted at Hannover Medical School, investigating the genetics of susceptibility to COVID-19.
Bionano Genomics to Publicly Offer Securities, Amends Loan Agreement
The genome mapping firm had fallen out of compliance with respect to its loan agreement with Innovatus and will prepay $5 million toward the loan principal.
Bionano Genomics Commences Public Stock Offering
The firm is offering approximately 13.8 million shares and the same number of warrants to purchase shares, which will be sold together.